期刊文献+

白藜芦醇影响高转移卵巢癌细胞HO-8910PM转移相关能力的实验研究 被引量:6

Study on the Effect of Resveratrol on Metastasis-associated Ability of Ovarian Carcinoma HO-8910PM Cells in Vitro
下载PDF
导出
摘要 目的:研究白藜芦醇对人高转移卵巢癌细胞HO-8910PM转移相关能力的影响。方法:以MTT法检测白藜芦醇对高转移卵巢癌细胞HO-8910PM的细胞毒作用;用Transwell小室法检测白藜芦醇对HO-8910PM细胞侵袭能力和趋化运动能力的影响;以细胞粘附人工重组基底膜实验检测白藜芦醇对HO-8910PM细胞粘附能力的影响。结果:白藜芦醇作用细胞6 h后能抑制HO-8910PM细胞体外趋化运动和粘附能力,其中100μmol/L抑制率分别为(30.1±10.8)%,(34.27±1.28)%,但白藜芦醇并不影响HO-8910PM细胞侵袭人工基底膜能力。结论:白藜芦醇能抑制高转移卵巢癌细胞HO-8910PM的运动和粘附能力,是潜在的抗肿瘤转移药物。 Objective: To investigate the inhibitory effect of resveratrol on the ted ability of human highly metastatic ovarian carcinoma HO-8910PM cells in vitro. Methods: MTT assay was used to examine the cytotoxicity of resveratrol in HO- 8910PM cells; Transwell Chamber assay was performed to determine the effect on invasion and migratory capacity of the cells by resveratrol; Effect on adhesion potential of HO-8910PM cells was tested by cell-Matrigel adhesion assay. Results: Resveratrol showed no cytotoxicity on HO-8910PM cells after 6 h treatment. Resveratrol significantly inhibited migration and adhesion capacity of HO-8910PM ceils in vitro. Their inhibitory rates after treated with the chemical Of 100 μmol/L for 6 h were (30. 1 ± 10. 8) %, (34. 27 ± 1.28) %, respectively. However, Resveratrol had no effect on invasion capacity of HO-8910PM cells. Conclusion: Resveratrol can inhibit the migration and adhesion of HO-8910PM cells in vitro. Resveratrol might be a potential drug to inhibit tumor metastasis.
出处 《中药材》 CAS CSCD 北大核心 2007年第2期176-178,共3页 Journal of Chinese Medicinal Materials
基金 国家自然科学基金资助课题(No.39870900) 湛江市"988"兴湛计划项目(No.ZK0104)
关键词 白藜芦醇 侵袭 运动 粘附 转移 卵巢癌 Resveratrol Invasion Migration Adhesion Metastasis Ovarian carcinoma
  • 相关文献

参考文献7

二级参考文献27

  • 1许沈华,牟瀚舟,钱丽娟,孙永正,朱赤红,黄晓曙,高永良,戴珊星.高转移人卵巢癌裸鼠皮下移植瘤模型的建立及其生物学特性[J].中华病理学杂志,1996,25(1):33-35. 被引量:15
  • 2Huang S, Pettaway CA, Uehara H, et al. Blockade of NFkappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis [J].Oncogene, 2001,20(31) :4188-4197.
  • 3Lin A, Karin M. NF-kappaB in cancer: a marked target [J].Semin Cancer Biol, 2003,13(2): 107-114.
  • 4Orlowski RZ, Baldwin AS. NF-kappaB as a therapeutic target in cancer [J]. Trends Mol Med, 2002,8(8):385-389.
  • 5Prager GW, Breuss JM, Steurer S, et al. Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA)activation on the surface of endothelial cells [J]. Blood, 2004,103(3) :955-962.
  • 6Huang S, RObinson JB, DeGuzman A, et al. Blockade of NFkappaB signalling inhibits angio- genesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin-8 [J]. Cancer Res, 2000,60(19) :5334-5339.
  • 7Atten MJ,Attar BM,Milson T,et al. Resveratrol-induced inactivation of human gastric sdenocarcinoma cells through a protein kinase C-mediated mechanism[J]. Biochem Pharmacol,2001;62(10):1423-1432.
  • 8Fabbro D,Parkinson D,Matter A. Protein tyrosine kinase inhibitors:New treatment modalityes[J]. Curr Opin Pharmacol,2002;2(4):374-381.
  • 9Asou H,Koshizuka K,Kyo T,et al. Resveratrol,a naturesl product derived from grapes,is a new inducer of differentiation in human myeloid leuke miasp[J]. Int J Hematol,2002;75(5):528-533.
  • 10Bhat KP, et al. Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci,2002,957:210.

共引文献88

同被引文献133

引证文献6

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部